Company
Headquarters: Central, Hong Kong
Employees: 3,214
CN¥23.72 Billion
CNY as of Jan. 1, 2025
US$3.25 Billion
Company | Market Cap (USD) |
---|---|
Linde | $209.90 B |
The Sherwin-Williams Company | $90.95 B |
Ecolab Inc. | $68.79 B |
Givaudan SA | $39.90 B |
PT. Chandra Asri Petrochemical Tbk | $37.92 B |
Company | Market Cap (USD) |
---|---|
Linde | $209.90 B |
BHP | $151.21 B |
Rio Tinto | $102.04 B |
Air Liquide SA | $97.26 B |
The Sherwin-Williams Company | $90.95 B |
Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA. The company also provides food grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food grade gamma aminobutyric acid under the Gabarelax name; and hyaluronic acid for oral, intimate, and animal care under the Biomoist, Hyadom, and HYAPET names. Bloomage BioTechnology Corporation Limited was founded in 2000 and is headquartered in Jinan, the People's Republic of China.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Last Financial Reports Date | Sept. 30, 2024 |
Revenue TTM | CN¥5.73 B |
EBITDA | CN¥639.6 M |
Gross Profit TTM | CN¥4.20 B |
Profit Margin | 7.68% |
Operating Margin | 6.21% |
Quarterly Revenue Growth | -7.10% |
Bloomage BioTechnology Corp Ltd has the following listings and related stock indices.
Stock: SSE: 688363 wb_incandescent